So for months we have all been arguing that RATs are crucially important to controlling Covid but now you are willing to remove (possibly) imperfect tests from the market so they don't compete with our as yet unapproved but (possibly) better test that will be available in indeterminate quantities at some indeterminate point after it eventual approval. That sounds a little extreme. I don't think that is going to happen.
ADO Price at posting:
17.5¢ Sentiment: Hold Disclosure: Held
